Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations

International Journal of Dermatology

Volumn 50, Issue 12, 2011, Pages 1496-1500

  Zavos, George ^a   Karidis, Nikolaos P ^b   Tsourouflis, Gerasimos ^a   Bokos, John ^a   Diles, Konstantinos ^a   Sotirchos, George ^a   Theodoropoulou, Eleni ^a   Kostakis, Alkiviadis ^b  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURGERY; CLINICAL ARTICLE; DISTANT METASTASIS; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; NONMELANOMA SKIN CANCER; RETROSPECTIVE STUDY; SEBACEOUS CARCINOMA; SKIN CANCER; SPLENECTOMY; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA, SEBACEOUS; ADULT; AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SEBACEOUS GLAND NEOPLASMS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 81855170011     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04939.x     Document Type: Article

References (22)

1. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905-913.
2. Ramsay HM, Reece SM, Fryer AA, et al. Seven-year prospective study of non-melanoma skin cancer incidence in UK renal transplant recipients. Transplantation 2007; 84: 437-439.
3. Bordea C, Wojnarowska F, Millard PR, et al. Skin cancers in renal transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77: 574-579.
4. Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for non-melanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30: 622-627.
5. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
6. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290-300.
7. Otley CC, Cherikh WS, Salasche SJ, et al. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol 2005; 53: 783-790.
8. Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin cancer in organ transplant recipients - where do we stand today? Am J Transplant 2008; 8: 2192-2198.
9. Laing ME, Kay E, Conlon P, Murphy GM. Genetic factors associated with skin cancer in renal transplant patients. Photodermatol Photoimmunol Photomed 2007; 23: 62-67.
10. de Graaf YG, Rebel H, Elghalbzouri A, et al. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine. Exp Dermatol 2008; 17: 349-355.
11. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J Investig Dermatol Symp Proc 2001; 6: 207-211.
12. Zavos G, Bokos J, Papaconstantinou J, et al. Study of "de novo" malignancies among Greek renal transplant recipients. Transplant Proc 2003; 35: 1399-1403.
13. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61: 715-721.
14. Hartevelt MM, Bavinck JN, Kootte AM, et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-509.
15. Perrem K, Lynch A, Conneely M, et al. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths. Hum Pathol 2007; 38: 351-358.
16. Hiesse C, Larue JR, Kriaa F, et al. Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients. Transplant Proc 1995; 27: 2450-2451.
17. Jensen P, Hansen S, Moller B, et al. Are renal transplant recipients on CsA-based immunosuppressive regimens more likely to develop skin cancer than those on azathioprine and prednisolone? Transplant Proc 1999; 31: 1120.
18. Kahan BD, Yakupoglu YK, Schoenberg L, et al. Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients. Transplantation 2005; 80: 749-758.
19. Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients: focus on rapamycin. Dermatol Surg 2004; 30: 628-633.
20. Dantal J, Hourmant M, Cantarovich D, et al. Effect of longterm immunosuppression in kidney graft recipients on cancer incidence: randomized comparison of two cyclosporine regimens. Lancet 1998; 351: 623-628.
21. Otley CC, Coldiron BM, Stasko T, Goldman GD. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137: 459-463.
22. Robinson JK, Rigel DS. Sun protection attitudes and behaviors of solid-organ transplant recipients. Dermatol Surg 2004; 30: 610-615.